Research and analysis

LFD sensitivity: manufacturer reported versus laboratory evaluation

This report presents the comparison of the sensitivity data provided by the manufacturer in the instructions for use with that observed in the laboratories at Porton Down.

Documents

Comparison of manufacturer reported lateral flow device sensitivity with the sensitivity observed in evaluation

Details

This report presents the comparison of manufacturer reported sensitivity data, as reported in the instructions for use, with the sensitivity data observed in the Phase 3 evaluation at Porton Down between August 2020 and November 2022.

For more information, see the protocol for the evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens (lateral flow devices).

Updates to this page

Published 21 March 2024

Sign up for emails or print this page